press-releases
Lunaphore and Epredia announce agreement for exclusive distribution of LabSat® Research
Date
We are happy to announce that we have entered into a distribution agreement with Epredia, a global leader in precision cancer diagnostics and tissue diagnostics.
Under the terms of this agreement, Epredia have been appointed the exclusive distributor of the LabSat® Research platform in the US, UK and Germany, where Epredia will start to distribute the product in July 2020, as well as Japan, where the commercialization will begin in 2021.
